Robert J Mentz1, Samuel Broderick2, Linda K Shaw2, Mona Fiuzat3, Christopher M O'Connor4. 1. Department of Medicine, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Duke University Medical Center, Durham, North Carolina. Electronic address: robert.mentz@duke.edu. 2. Duke Clinical Research Institute, Durham, North Carolina. 3. Department of Medicine, Duke University Medical Center, Durham, North Carolina; Division of Clinical Pharmacology, Duke University Medical Center, Durham, North Carolina. 4. Department of Medicine, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Abstract
OBJECTIVES: This study investigated the characteristics and outcomes of patients with heart failure with preserved ejection fraction (HFpEF) and angina pectoris (AP). BACKGROUND: AP is a predictor of adverse events in patients with heart failure with reduced EF. The implications of AP in HFpEF are unknown. METHODS: We analyzed HFpEF patients (EF ≥50%) who underwent coronary angiography at Duke University Medical Center from 2000 through 2010 with and without AP in the previous 6 weeks. Time to first event was examined using Kaplan-Meier methods for the primary endpoint of death/myocardial infarction (MI)/revascularization/stroke (i.e., major adverse cardiac events [MACE]) and secondary endpoints of death/MI/revascularization, death/MI/stroke, death/MI, death, and cardiovascular death/cardiovascular hospitalization. RESULTS: In the Duke Databank, 3,517 patients met criteria for inclusion and 1,402 (40%) had AP. Those with AP were older with more comorbidities and prior revascularization compared with non-AP patients. AP patients more often received beta-blockers, angiotensin-converting enzyme inhibitors, nitrates, and statins (all p < 0.05). In unadjusted analysis, AP patients had increased MACE and death/MI/revascularization (both p < 0.001), lower rates of death and death/MI (both p < 0.05), and similar rates of death/MI/stroke and cardiovascular death/cardiovascular hospitalization (both p > 0.1). After multivariable adjustment, those with AP remained at increased risk for MACE (hazard ratio [HR]: 1.30, 95% confidence interval [CI]: 1.17 to 1.45) and death/MI/revascularization (HR: 1.29, 95% CI: 1.15 to 1.43), but they were at similar risk for other endpoints (p > 0.06). CONCLUSIONS: AP in HFpEF patients with a history of coronary artery disease is common despite medical therapy and is independently associated with increased MACE due to revascularization with similar risk of death, MI, and hospitalization.
OBJECTIVES: This study investigated the characteristics and outcomes of patients with heart failure with preserved ejection fraction (HFpEF) and angina pectoris (AP). BACKGROUND: AP is a predictor of adverse events in patients with heart failure with reduced EF. The implications of AP in HFpEF are unknown. METHODS: We analyzed HFpEF patients (EF ≥50%) who underwent coronary angiography at Duke University Medical Center from 2000 through 2010 with and without AP in the previous 6 weeks. Time to first event was examined using Kaplan-Meier methods for the primary endpoint of death/myocardial infarction (MI)/revascularization/stroke (i.e., major adverse cardiac events [MACE]) and secondary endpoints of death/MI/revascularization, death/MI/stroke, death/MI, death, and cardiovascular death/cardiovascular hospitalization. RESULTS: In the Duke Databank, 3,517 patients met criteria for inclusion and 1,402 (40%) had AP. Those with AP were older with more comorbidities and prior revascularization compared with non-AP patients. AP patients more often received beta-blockers, angiotensin-converting enzyme inhibitors, nitrates, and statins (all p < 0.05). In unadjusted analysis, AP patients had increased MACE and death/MI/revascularization (both p < 0.001), lower rates of death and death/MI (both p < 0.05), and similar rates of death/MI/stroke and cardiovascular death/cardiovascular hospitalization (both p > 0.1). After multivariable adjustment, those with AP remained at increased risk for MACE (hazard ratio [HR]: 1.30, 95% confidence interval [CI]: 1.17 to 1.45) and death/MI/revascularization (HR: 1.29, 95% CI: 1.15 to 1.43), but they were at similar risk for other endpoints (p > 0.06). CONCLUSIONS: AP in HFpEF patients with a history of coronary artery disease is common despite medical therapy and is independently associated with increased MACE due to revascularization with similar risk of death, MI, and hospitalization.
Authors: Benjamin A Steinberg; Xin Zhao; Paul A Heidenreich; Eric D Peterson; Deepak L Bhatt; Christopher P Cannon; Adrian F Hernandez; Gregg C Fonarow Journal: Circulation Date: 2012-05-21 Impact factor: 29.690
Authors: John G Canto; Contessa Fincher; Catarina I Kiefe; Jeroan J Allison; Qing Li; Ellen Funkhouser; Robert M Centor; Harry P Selker; Norman W Weissman Journal: Am J Cardiol Date: 2002-08-01 Impact factor: 2.778
Authors: R A Kloner; T Shook; K Przyklenk; V G Davis; L Junio; R V Matthews; S Burstein; M Gibson; W K Poole; C P Cannon Journal: Circulation Date: 1995-01-01 Impact factor: 29.690
Authors: Gregory M Ouellet; Mary Geda; Terrence E Murphy; Sui Tsang; Mary E Tinetti; Sarwat I Chaudhry Journal: J Am Geriatr Soc Date: 2017-10-18 Impact factor: 5.562
Authors: Yuliya Lytvyn; Petter Bjornstad; Jacob A Udell; Julie A Lovshin; David Z I Cherney Journal: Circulation Date: 2017-10-24 Impact factor: 29.690
Authors: Kishan S Parikh; Adrian Coles; Phillip J Schulte; William E Kraus; Jerome L Fleg; Steven J Keteyian; Ileana L Piña; Mona Fiuzat; David J Whellan; Christopher M O'Connor; Robert J Mentz Journal: Am J Cardiol Date: 2016-07-29 Impact factor: 2.778
Authors: Robert J Mentz; Samuel Broderick; Linda K Shaw; Karen Chiswell; Mona Fiuzat; Christopher M O'Connor Journal: Eur J Heart Fail Date: 2014-06-27 Impact factor: 15.534
Authors: Pamela Ouyang; Nanette K Wenger; Doris Taylor; Janet W Rich-Edwards; Meir Steiner; Leslee J Shaw; Sarah L Berga; Virginia M Miller; Noel Bairey Merz Journal: Biol Sex Differ Date: 2016-03-31 Impact factor: 5.027
Authors: Rohan Samson; Abhishek Jaiswal; Pierre V Ennezat; Mark Cassidy; Thierry H Le Jemtel Journal: J Am Heart Assoc Date: 2016-01-25 Impact factor: 5.501